Binding and inhibitory effect of ravidasvir on 3CL^pro of SARS-CoV‐2: a molecular docking, molecular dynamics and MM/PBSA approach

References

• Alothaid, H., Aldughaim, M. S. K., El Bakkouri, K., AlMashhadi, S., & Al-Qahtani, A. A. (2020). Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: A review of potential targets for diagnosis and treatment. Channels (Austin, Tex.), 14(1), 403–412. https://doi.org/10.1080/19336950.2020.1837439
   PubMed Web of Science ®Google Scholar
• Amadei, A., Linssen, A. B. M., & Berendsen, H. J. C. (1993). Essential dynamics of proteins. Proteins: Structure, Function, and Bioinformatics, 17(4), 412–425. https://doi.org/10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450–452. https://doi.org/10.1038/s41591-020-0820-9
   PubMed Web of Science ®Google Scholar
• Bafna, K., Krug, R. M., & Montelione, G. T. (2020). Structural similarity of SARS-CoV2 Mpro and HCV NS3/4A proteases suggests new approaches for identifying existing drugs useful as COVID-19 therapeutics. ChemRxiv. https://doi.org/10.26434/chemrxiv.12153615
   PubMedGoogle Scholar
• Behloul, N., Baha, S., Guo, Y., Yang, Z., Shi, R., & Meng, J. (2021). In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain. European Journal of Pharmacology, 890, 173701. https://doi.org/10.1016/j.ejphar.2020.173701
   Google Scholar
• Bera, K., Rani, P., Kishor, G., Agarwal, S., Kumar, A., & Singh, D. V. (2018). Structural elucidation of transmembrane domain zero (TMD0) of EcdL: A multidrug resistance-associated protein (MRP) family of ATP-binding cassette transporter protein revealed by atomistic simulation. Journal of Biomolecular Structure & Dynamics, 36(11), 2938–2950. https://doi.org/10.1080/07391102.2017.1372311
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., & Hermans, J. (1981). Interaction models for water in relation to protein hydration. In B. Pullman (Ed.), Intermolecular forces: Proceedings of the Fourteenth Jerusalem Symposium on Quantum Chemistry and Biochemistry Held in Jerusalem, Israel, April 13–16, 1981 (pp. 331–342). Springer Netherlands. https://doi.org/10.1007/978-94-015-7658-1_21
   Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. The Journal of Chemical Physics, 126(1), 014101. https://doi.org/10.1063/1.2408420
   PubMed Web of Science ®Google Scholar
• Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections, 9(1), 221–236. https://doi.org/10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Chandra, A., Goyal, N., Qamar, I., & Singh, N. (2020). Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics, 0(0), 1–9. https://doi.org/10.1080/07391102.2020.1734487
   PubMedGoogle Scholar
• Chandra, A., Gurjar, V., Qamar, I., & Singh, N. (2020). Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: A drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics, 0(0), 1–11. https://doi.org/10.1080/07391102.2020.1775127
   PubMedGoogle Scholar
• Chatterjee, S., Maity, A., Chowdhury, S., Islam, M. A., Muttinini, R. K., & Sen, D. (2020). In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme. Journal of Biomolecular Structure and Dynamics, 0(0), 1–14. https://doi.org/10.1080/07391102.2020.1787228
   PubMedGoogle Scholar
• Chen, H., Zhang, Z., Wang, L., Huang, Z., Gong, F., Li, X., Chen, Y., & Wu, J. J. (2020). First clinical study using HCV protease inhibitor danoprevir to treat naïve and experienced COVID-19 patients. MedRxiv. https://doi.org/10.1101/2020.03.22.20034041
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Fox, M. J. F., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A. V., Bloino, J., Janesko, B. G., Gomperts, R., Mennucci, B., Hratchian, H. P., Ortiz, J. V.,… Foresman, D. J. (2016).Gaussian 16, Revision C.01. Gaussian, Inc. https://gaussian.com/
   Google Scholar
• Goyal, B., & Goyal, D. (2020). Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic strategy. ACS Combinatorial Science, 22(6), 297–305. https://doi.org/10.1021/acscombsci.0c00058
   PubMed Web of Science ®Google Scholar
• He, J., Lijun, H., Xiaojun, H., Chenran, W., Zhimin, Z., Ying, W., Dongmei, Z., & Wencai, Y. (2020). Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors. International Journal of Antimicrobial Agents, 56(2), 106055. https://doi.org/10.1016/j.ijantimicag.2020.106055
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Huang, Y., Yang, C., Xu, X., Xu, W., & Liu, S. (2020). Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 41(9), 1141–1149. https://doi.org/10.1038/s41401-020-0485-4
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D. A., & Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889–897. https://doi.org/10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins: Structure, Function, and Bioinformatics, 78(8), 1950–1958. https://doi.org/10.1002/prot.22711
   PubMed Web of Science ®Google Scholar
• Lokhande, K., Nawani, N., Venkateswara, S. K., & Pawar, S. (2020). Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: A molecular docking and molecular dynamics approach. Journal of Biomolecular Structure and Dynamics, 0(0), 1–13. https://doi.org/10.1080/07391102.2020.1858165
   Google Scholar
• Mahapatra, M. K., Bera, K., Singh, D. V., Kumar, R., & Kumar, M. (2018). In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors. Journal of Biomolecular Structure & Dynamics, 36(5), 1195–1211. https://doi.org/10.1080/07391102.2017.1317026
   PubMed Web of Science ®Google Scholar
• Martínez-Rosell, G., Giorgino, T., & De Fabritiis, G. (2017). PlayMolecule ProteinPrepare: A web application for protein preparation for molecular dynamics simulations. Journal of Chemical Information and Modeling, 57(7), 1511–1516. https://doi.org/10.1021/acs.jcim.7b00190
   PubMed Web of Science ®Google Scholar
• Maurya, D. K., & Sharma, D. (2020). Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach. Journal of Biomolecular Structure and Dynamics, 0(0), 1–16. https://doi.org/10.1080/07391102.2020.1852119
   PubMedGoogle Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/10.1063/1.328693
   Web of Science ®Google Scholar
• Pharco Pharmaceuticals. (2016). A Phase IIb/IIIa, Randomized Study to Evaluate the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4 (Clinical Trial Registration No. NCT02371408). clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT02371408
   Google Scholar
• Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016). An Overview of severe acute respiratory syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. Journal of Medicinal Chemistry, 59(14), 6595–6628. https://doi.org/10.1021/acs.jmedchem.5b01461
   PubMed Web of Science ®Google Scholar
• Ray, A. K., Gupta, P. S. S., Panda, S. K., Biswal, S., & Rana, M. K. (2020). Repurposing of FDA Approved Drugs for the Identification of Potential Inhibitors of SARS-CoV-2 Main Protease. Preprint. https://doi.org/10.26434/chemrxiv.12278066.v2
   Google Scholar
• Ren, J., Yuan, X., Li, J., Lin, S., Yang, B., Chen, C., Zhao, J., Zheng, W., Liao, H., Yang, Z., & Qu, Z. (2020). Assessing the performance of the g_mmpbsa tools to simulate the inhibition of oseltamivir to influenza virus neuraminidase by molecular mechanics Poisson–Boltzmann surface area methods. Journal of the Chinese Chemical Society, 67(1), 46–53. https://doi.org/10.1002/jccs.201900148
   Web of Science ®Google Scholar
• SARS-CoV-2 main protease. (2020, March 25). https://www.wwpdb.org/pdb?id=pdb_00006yb7
   Google Scholar
• Schmid, N., Eichenberger, A. P., Choutko, A., Riniker, S., Winger, M., Mark, A. E., & van Gunsteren, W. F. (2011). Definition and testing of the GROMOS force-field versions 54A7 and 54B7. European Biophysics Journal: EBJ, 40(7), 843–856. https://doi.org/10.1007/s00249-011-0700-9
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652. https://doi.org/10.1016/j.lfs.2020.117652
   PubMed Web of Science ®Google Scholar
• Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE – AnteChamber PYthon Parser interfacE. BMC Res Notes, 5(1), 367. https://doi.org/10.1186/1756-0500-5-367
   PubMedGoogle Scholar
• Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006). Protein–ligand docking: Current status and future challenges. Proteins: Structure, Function, and Bioinformatics, 65(1), 15–26. https://doi.org/10.1002/prot.21082
   PubMed Web of Science ®Google Scholar
• Srinivasan, J., Cheatham, T. E., Cieplak, P., Kollman, P. A., & Case, D. A. (1998). Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate − DNA Helices. Journal of the American Chemical Society, 120(37), 9401–9409. https://doi.org/10.1021/ja981844+
   Web of Science ®Google Scholar
• Sven, U., & Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters, 30(17), 127377. https://doi.org/10.1016/j.bmcl.2020.127377
   PubMed Web of Science ®Google Scholar
• Teeter, M. M., & Case, D. A. (1990). Harmonic and quasiharmonic descriptions of crambin. The Journal of Physical Chemistry, 94(21), 8091–8097. https://doi.org/10.1021/j100384a021
   Web of Science ®Google Scholar
• Tripathi, N., Goel, B., Bhardwaj, N., Sahu, B., Kumar, H., & Jain, S. K. (2020). Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 0(0), 1–13. https://doi.org/10.1080/07391102.2020.1848630
   PubMedGoogle Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• WHO Weekly Epidemiological updates. (2021, January). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210127_weekly_epi_update_24.pdf?sfvrsn=a8d660fc_9&download=true
   Google Scholar
• Xu, X., Feng, B., Guan, Y., Zheng, S., Sheng, J., Yang, X., Ma, Y., Huang, Y., Kang, Y., Wen, X., Li, J., Tan, Y., He, Q., Xie, Q., Wang, M., An, P., Gong, G., Liu, H., Ning, Q., … Wei, L. (2019). Efficacy and safety of all-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin in treatment-naïve noncirrhotic HCV genotype 1 patients: Results from a phase 2/3 clinical trial in China. Journal of Clinical and Translational Hepatology, 7(3), 1–220. https://doi.org/10.14218/JCTH.2019.00033
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar